MoneyWorks4Me

Aarey Drugs & Pharma - Quaterly Results

14 Nov 2022 Evaluate
The sales moved down -43.36% to Rs. 762.61 millions for the September 2022 quarter as compared to Rs. 1346.49 millions during the corresponding quarter last year.The Net Profit of the company registered a slight decline of -25.49% to Rs. 21.19  millions from Rs. 28.44 millions.A decline of 33.31 millions was observed in the OP in the quarter ended September 2022 from 42.33 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 762.61 1346.49 -43.36 1936.02 2321.67 -16.61 4926.80 3484.16 41.41
Other Income -9.41 8.15 -215.46 14.13 14.86 -4.91 27.48 70.15 -60.83
PBIDT 33.31 42.33 -21.31 50.86 78.32 -35.06 140.15 116.53 20.27
Interest 5.91 6.09 -2.96 11.39 10.80 5.46 20.00 24.32 -17.76
PBDT 27.40 36.24 -24.39 39.47 67.52 -41.54 120.15 92.21 30.30
Depreciation 4.16 5.00 -16.80 8.23 9.00 -8.56 19.88 9.20 116.09
PBT 23.24 31.24 -25.61 31.24 58.52 -46.62 100.27 83.01 20.79
TAX 2.05 2.80 -26.79 2.05 5.00 -59.00 34.82 17.87 94.85
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -1.08 1.23 -187.80
PAT 21.19 28.44 -25.49 29.19 53.52 -45.46 65.45 65.14 0.48
Equity 253.85 233.84 8.56 253.85 233.85 8.55 253.85 233.85 8.55
PBIDTM(%) 4.37 3.14 38.94 2.63 3.37 -22.13 2.84 3.34 -14.95
Peers